Streetinvesting.com: Market Review on Cell Genesys, Inc.

tmcnet.com     May 21, 2008            

Streetinvesting.com has now resumed our progressive Cell Genesys, Inc. (NASDAQ:CEGE) as it opened up $0.12 on below average volume early trading Wednesday, May 21, 2008. Cell Genesys, Inc. reported encouraging interim data from the expansion cohort of the Phase 1, multicenter clinical trial of... [read full story]                

Add a comment to the article
Type the code shown